Impact of Erector Spinae Plane Blocks on Pain Management and Postoperative Outcomes in Patients with Chronic Pain Undergoing Spine Fusion Surgery: A Retrospective Cohort Study
Krizia Amoroso,James Beckman,Jiaqi Zhu,Erika Chiapparelli,Ali Guven,Jennifer Shue,Andrew Sama,Federico Girardi,Frank Cammisa,Alexander Hughes,Ellen Soffin
DOI: https://doi.org/10.2147/jpr.s483144
IF: 2.8319
2024-11-28
Journal of Pain Research
Abstract:Krizia Amoroso, 1, 2 James A Beckman, 1 Jiaqi Zhu, 3 Erika Chiapparelli, 2 Ali E Guven, 2 Jennifer Shue, 2 Andrew A Sama, 2 Federico P Girardi, 2 Frank P Cammisa, 2 Alexander P Hughes, 2 Ellen M Soffin 1 1 Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery, New York, NY, USA; 2 Orthopedic Surgery, Spine Care Institute, Hospital for Special Surgery, New York, NY, USA; 3 Biostatistics Core, Hospital for Special Surgery, New York, NY, USA Correspondence: Ellen M Soffin, Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA, Email Purpose: To evaluate the impact of bilateral ultrasound-guided erector spinae plane blocks (ESPBs) on pain and opioid-related outcomes in a surgical population with chronic pain. Methods: A retrospective, observational cohort study. Clinical data were extracted from the electronic medical records of patients who underwent lumbar fusion (February 2018 – July 2020). Eligible patients had a confirmed history/diagnosis of chronic pain starting > 3 months before surgery and received either bilateral ESPBs or no ESPBs. Patients were matched on demographic variables (sex, age, race, BMI, ASA Classification, and preoperative opioid use) in a 1:1 ratio. The primary outcome was median opioid consumption (morphine equivalent dose, MED) 24 hours post-surgery (hydromorphone iv-PCA and oral). Secondary outcomes included Numeric Rating Scale (NRS) pain scores, opioid consumption up to 48 hours post-surgery, and hospital length of stay (LOS). Group differences were analyzed using bivariable and multivariable regression. Results: Of 72 patients, 36 received ultrasound-guided ESPBs and 36 did not. Baseline demographics showed no significant differences. On bivariable analysis, ESPBs were associated with significantly lower 24-hour opioid consumption (79 mg MED vs 116 mg MED, p=0.024) and shorter LOS (82 hours, 95% CI 51– 106 vs 126 hours, 95% CI 101– 167, p< 0.001). No significant differences in NRS pain scores were found up to 48 hours post-surgery. Multivariable analysis confirmed significant reductions in 24-hour opioid consumption (− 44, 95% CI − 1.06 - − 87.55, p=0.044), IV-PCA use (− 22, 95% CI − 1.59 - − 56.77, p=0.038), and LOS (− 38, 95% CI − 10.074 - − 66.22, p=0.008) in the ESPB group without differences in NRS pain scores. Conclusion: ESPBs were associated with statistically and clinically significant reductions in 24-hour opioid consumption and LOS, without differences in NRS pain scores after spinal fusion in a chronic pain surgical cohort. Given these effects, patients with chronic pain may disproportionately benefit from ESPBs for spine surgery. Keywords: chronic pain, erector spinae plane block, spine surgery, lumbar, thoracolumbar, outcomes Chronic pain and opioid tolerance are frequently reported in patients presenting for spine surgery. 1,2 Both are known to influence the clinical course, outcomes and length of hospital stay after spine surgery. Chronic pain, by its nature, leads to altered pain perception and often results in opioid tolerance due to prolonged use of analgesic medications. Patients with chronic pain often experience increased pain intensity and greater difficulty managing postoperative pain, making their care more complex and requiring multimodal pain management strategies. These patients are more likely to experience heightened central sensitization, which makes traditional pain relief methods, such as opioids, less effective. Despite (or potentially because of) these effects, patients with chronic pain and opioid tolerance are frequently excluded from studies of acute pain interventions in the perioperative period. For example, a recent systematic review synthesizing the benefits of bilateral erector spinae plane blocks (ESPB) in lumbar spine surgery specifically excluded studies from analysis if they had included patients "...with a history of chronic pain and opioid dependence". 3 Excluding patients with opioid tolerance and chronic pain from the underlying trials and from the systematic reviews compromises our ability to generalize the potential benefits of acute pain interventions to this surgical population. Further, we risk compromising the care of patients who may be the most at-risk of poorly controlled post-operative pain and opioid-related harms. In parallel, effective pain management for all patients undergoing spine surgery remains challenging, often requiring a multidisciplinary, multimodal approach to care. Recent advances in multimodal analgesic regimens for lumba -Abstract Truncated-
clinical neurology